Shiho Yamamoto

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 553 citations · Full text

Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · 2022 · 56 citations · Full text

Coronavirus Disease 2019, Molecular Pharmacology, Medicinal Chemistry +15

Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial

Yuji Koriyama, Akihiro Hori, Hisanori Ito et al. · Journal of Medicinal Chemistry · 2021 · 48 citations · Full text

Operational Strategies of Networked Fuel Cells in Residential Homes

Hirohisa Aki, Shiho Yamamoto, Yoshiro Ishikawa et al. · IEEE Transactions on Power Systems · 2006 · 37 citations

Engineering, Energy Efficiency, Home Energy Storage +18

Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza A in the Tokyo area

Masaru Terai, Takafumi Honda, Shiho Yamamoto et al. · Microbiology and Immunology · 2011 · 26 citations · Full text

Asthma, Inflammatory Lung Disease, Lung Inflammation +17